Abstract
Cancer, a global concern, is characterized by the uncontrolled growth of cells, often driven by genetic mutations. Breast cancer, notably triple-negative breast cancer (TNBC), represents a significant therapeutic challenge due to its aggressiveness and lack of specific estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2). In this contex…